598 related articles for article (PubMed ID: 25450438)
1. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
[TBL] [Abstract][Full Text] [Related]
2. [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines].
Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
Clin Investig Arterioscler; 2015; 27(1):36-44. PubMed ID: 25444651
[TBL] [Abstract][Full Text] [Related]
3. Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines.
Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR; ;
Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):913-9. PubMed ID: 25443815
[TBL] [Abstract][Full Text] [Related]
4. [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management. Differences Between the European and American Guidelines].
Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
Hipertens Riesgo Vasc; 2015; 32(2):83-91. PubMed ID: 26179969
[TBL] [Abstract][Full Text] [Related]
5. Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management: differences between the European and American Guidelines.
Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR; ;
Rev Esp Salud Publica; 2015; 89(1):15-26. PubMed ID: 25946582
[TBL] [Abstract][Full Text] [Related]
6. [Guidelines for the management of dyslipidemia].
Díaz Rodríguez Á;
Semergen; 2014 Sep; 40 Suppl 4():19-25. PubMed ID: 25595349
[TBL] [Abstract][Full Text] [Related]
7. Practical recommendations for the management of cardiovascular risk associated with atherogenic dyslipidemia, with special attention to residual risk. Spanish adaptation of a European Consensus of Experts.
Grupo de trabajo de Dislipemia Aterogénica de la Sociedad Española de Arteriosclerosis y Grupo Europeo de Expertos
Clin Investig Arterioscler; 2017; 29(4):168-177. PubMed ID: 28433209
[TBL] [Abstract][Full Text] [Related]
8. The new dyslipidemia guidelines: what is the debate?
Anderson TJ; Mancini GB; Genest J; Grégoire J; Lonn EM; Hegele RA
Can J Cardiol; 2015 May; 31(5):605-12. PubMed ID: 25816728
[TBL] [Abstract][Full Text] [Related]
9. Impact of the new American and British guidelines on the management and treatment of dyslipidemia in a Spanish working population.
Brotons C; Calvo-Bonacho E; Moral I; García-Margallo MT; Cortés-Arcas MV; Puig M; Vázquez-Pirillo G; Ruilope LM
Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):906-11. PubMed ID: 25278212
[TBL] [Abstract][Full Text] [Related]
10. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Bruckert E; Ferrières J
Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
[TBL] [Abstract][Full Text] [Related]
11. [Recommendations of the European Society of Cardiology and the European Atherosclerosis Society on Cardiovascular Disease Prevention and Management of Dyslipidemias. for the Diagnosis of Atherosclerosis and Dyslipidemia Treatment (2016): Basic S.G.].
Bubnova MG; Kukharchuk VV
Kardiologiia; 2017 Mar; 57(3):85-89. PubMed ID: 28762942
[TBL] [Abstract][Full Text] [Related]
12. What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, the NLA recommendations, and beyond.
Waite LH; Phan YL; Spinler SA
J Am Pharm Assoc (2003); 2016; 56(3):284-92. PubMed ID: 27156942
[TBL] [Abstract][Full Text] [Related]
13. Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia.
Dake AW; Sora ND
Am J Med Sci; 2016 Apr; 351(4):361-5. PubMed ID: 27079341
[TBL] [Abstract][Full Text] [Related]
14. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
15. Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines.
Pavlović J; Greenland P; Franco OH; Kavousi M; Ikram MK; Deckers JW; Ikram MA; Leening MJG
Circ Cardiovasc Qual Outcomes; 2021 Sep; 14(9):e007183. PubMed ID: 34546786
[TBL] [Abstract][Full Text] [Related]
16. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
[TBL] [Abstract][Full Text] [Related]
17. [Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines].
Royo-Bordonada MA; Lobos Bejarano JM; Villar Alvarez F; Sans S; Pérez A; Pedro-Botet J; Moreno Carriles RM; Maiques A; Lizcano A; Lizarbe V; Gil Núñez A; Fornés Ubeda F; Elosua R; de Santiago Nocito A; de Pablo Zarzosa C; de Álvaro Moreno F; Cortés O; Cordero A; Camafort Babkowski M; Brotons Cuixart C; Armario P;
Clin Investig Arterioscler; 2013; 25(3):127-39. PubMed ID: 23726872
[TBL] [Abstract][Full Text] [Related]
18. [Are therapeutic LDL goals justified? Controversies between the European and American guidelines].
Bertomeu-Martínez V
Medwave; 2016 Dec; 16(Suppl4):e6825. PubMed ID: 28055995
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of dyslipidemia in 2014: European versus American guidelines].
Radermecker RP
Rev Med Suisse; 2014 Aug; 10(439):1534-7. PubMed ID: 25272669
[TBL] [Abstract][Full Text] [Related]
20. A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology.
Joshi PH; Chaudhari S; Blaha MJ; Jones SR; Martin SS; Post WS; Cannon CP; Fonarow GC; Wong ND; Amsterdam E; Hirshfeld JW; Blumenthal RS
Clin Cardiol; 2012; 35(7):404-9. PubMed ID: 22674150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
